Rhumbline Advisers Trims Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Rhumbline Advisers cut its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,456 shares of the biotechnology company’s stock after selling 1,989 shares during the period. Rhumbline Advisers’ holdings in Ligand Pharmaceuticals […]
Rhumbline Advisers cut its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,456 shares of the biotechnology company’s stock after selling 1,989 shares during the period. Rhumbline Advisers’ holdings in Ligand Pharmaceuticals […]
